AbbVie shuts down Rova-T development in first-line advanced small-cell lung cancer following another trial failure
August 30, 2019Medical Communications, Research and Development AbbVie, pharma, rova-t, small-cell lung cancer
AbbVie has announced its intention to terminate development of Rova-T (rovalpituzumab tesirine) in the first-line maintenance of advanced small-cell lung …
Using advanced digital capabilities to unlock hard-to-see HCPs access
August 29, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing digital pharma, pharma, veeva
Pharmaceutical companies face a ‘digital imperative’ to engage with healthcare professionals through their channel preferences and ensure they are getting …
Celgene signs $1.5bn partnership with Immatics to fight cancer with engineered T-cell therapies
August 29, 2019Research and Development Cancer, Celgene, immatics, immunotherapy, pharma
Celgene and biopharma firm Immatics Biotechnologies have announced that they have entered a partnership valued at a potential $1.5 billion …
FDA warns three Hepatitis C drugs may worsen liver function in some rare cases
August 29, 2019Medical Communications, Research and Development AbbVie, FDA, Gilead, HCV, MSD, hepatitis C, public health
The FDA has warned that three Hepatitis C (HCV) drugs made by AbbVie, Gilead and MSD are worsening liver function …
AstraZeneca lupus drug makes comeback to meet main goal at Phase 3
August 29, 2019Research and Development AstraZeneca, Lupus, anifrolumab, pharma
AstraZeneca has lifted the curtain on new Phase 3 data for anifrolumab, noting that the drug met its primary endpoint …
Oral contraceptive use as teenager linked to depression as an adult, study says
August 29, 2019Research and Development MDD, depression, hormones, oral contraceptives, psychiatry, psychology
Women who have used oral contraceptives as teenagers are more likely to experience depression later in life, according to a …
Alexion’s Soliris scoops up expanded EU approval in neuromyelitis optica spectrum disorder
August 28, 2019Research and Development, Sales and Marketing Alexion, FDA, US, pharma, soliris
Alexion has announced the expanded EU approval of Soliris (eculizumab) as a treatment for neuromyelitis optica spectrum disorder (NMOSD) in …
Sea snail chemical could be used as preventative treatment for bowel cancer, study shows
August 28, 2019Research and Development Australia, Cancer, bowel cancer, pharma, research
A chemical produced by Australian sea snails is showing promise as a potential treatment for cancer, according to researchers from …
Johns Hopkins researchers to study psilocybin as a treatment for anorexia in Phase 1 trial
August 28, 2019Research and Development Johns Hopkins, Magic mushrooms, anorexia, mushrooms, pharma, psilocybin
Scientists at Johns Hopkins University are exploring psilocybin as a potential treatment for chronic anorexia nervosa. Researchers at Johns Hopkins …
Over half of all US/EU regulator warnings issued to Indian and Chinese manufacturers, report finds
August 28, 2019Manufacturing and Production, Research and Development China, India, MHRA, UK, manufacturing, pharma
Concerns have been raised concerning the integrity of the global supply chain after a report from The Pharmaceutical Journal revealed …
Sacklers could give up Purdue Pharma and settle 2,000 lawsuits for $10-12 billion, proposal says
August 28, 2019Research and Development OxyContin, Purdue Pharma, Sackler family, opioid crisis, opioids, pharma
The Sackler family are offering to settle more than 2,000 opioid crisis lawsuits for between $10-12 billion, according to NBC. …
Working Life: Linda Armstrong, Global Head, Respiratory Development Unit at Novartis
August 27, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Working Life, feature, pharma
Linda Armstrong, Global Head, Respiratory Development Unit at Novartis.
FibroGen rocked by unexpected death of CEO Thomas B Neff
August 27, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, fibrogen, pharma
In a saddening turn of events, San Francisco-based FibroGen has announced that Thomas B Neff, its Chief Executive Officer and …
NICE refuses GW Pharma’s cannabis-based Epidyolex for treatment-resistant epilepsy
August 27, 2019Manufacturing and Production, Sales and Marketing Epidiolex, Epidyolex, GW Pharma, NICE, cannabidiol, cannabis, pharma
UK-based GW Pharma has suffered a setback in its home country after drug watchdog NICE chose not to recommend NHS …
The Royal College of Obstetricians and Gynaecologists (RCOG) call for action over shortages of hormone replacement therapy (HRT)
August 27, 2019Manufacturing and Production HRT, UK, healthcare, pharma, shortages
The Royal College of Obstetricians and Gynaecologists (RCOG) have called for action from government and pharmaceutical companies to adress ongoing …
J&J must pay $572 million for fuelling opioid crisis in Oklahoma, judge says
August 27, 2019Manufacturing and Production J&J, JJ, Johnson & Johnson, Oklahoma, opioid crisis, opioids, pharma
A judge in Oklahoma has said that Johnson & Johnson must pay $572 million for the part it played in …
Four perspectives from life sciences companies on multichannel engagement
August 23, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, Biogen, GSK, Lifesciences, Teva, healthcare, pharma
By 2020, 70% of HCPs are expected to be digital natives, whose experiences with mobile, social, and digital technologies in …
Japan approves Genmab’s Darzalex in newly diagnosed multiple myeloma
August 22, 2019Sales and Marketing
Genmab has secured a new approval for its CD38 monoclonal antibody Darzalex (daratumumab), this time in Japan for the treatment …
NICE Chief Sir Andrew Dillon to step down in 2020
August 22, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NICE, UK pharma, UK< pharma
It’s the end of an era at the National Institute of Health and Care Excellence (NICE), the UK watchdog responsible …
HHS to fund production of MSD’s Ebola vaccine V920
August 22, 2019Manufacturing and Production Ebola, HHS, MSD, Vaccine, pharma
The US Department of Health and Human Services (HHS) has said it will fund the production of MSD’s investigational Ebola …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
